Aurobindo Pharma gets USFDA nod for anti-allergic drug

Aurobindo Pharma has received the final approval for Cetirizine Hydrochloride syrup from USFDA. The approval of cetirizine hydrochloride syrup is under prescription drug product category.  Cetrizine Hydrochloride syrup is indicated for the relief  of syptoms associated with seasonal allergic rhinitis in adults and children above 2 years of age and falls under the anti allergic segment.

Aurobindo has a total of 110 ANDA approvals (82 final approvals and 28 tentative approvals) from USFDA.